MARKET

TLSI

TLSI

TriSalus Life Sciences Inc.
NASDAQ
4.520
-0.230
-4.84%
After Hours: 4.520 0 0.00% 16:49 02/09 EST
OPEN
4.680
PREV CLOSE
4.750
HIGH
4.750
LOW
4.470
VOLUME
130.35K
TURNOVER
--
52 WEEK HIGH
7.95
52 WEEK LOW
3.420
MARKET CAP
225.84M
P/E (TTM)
-2.2421
1D
5D
1M
3M
1Y
5Y
1D
TriSalus Life Sciences Announces New Board Appointment
TipRanks · 13h ago
TriSalus Life Sciences appoints Stansky to board of directors
TipRanks · 13h ago
TriSalus Life Sciences Appoints Michael Stansky to Board
Reuters · 14h ago
TRISALUS LIFE SCIENCES APPOINTS VETERAN HEALTHCARE INVESTOR MICHAEL STANSKY TO ITS BOARD OF DIRECTORS
Reuters · 14h ago
*TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to Its Bd of Directors
Dow Jones · 14h ago
Weekly Report: what happened at TLSI last week (0202-0206)?
Weekly Report · 18h ago
Weekly Report: what happened at TLSI last week (0126-0130)?
Weekly Report · 02/02 09:35
Weekly Report: what happened at TLSI last week (0119-0123)?
Weekly Report · 01/26 09:36
More
About TLSI
TriSalus Life Sciences, Inc. is an oncology-focused medical technology company. The Company is seeking to transform outcomes for patients with solid tumors by integrating its delivery technology with standard-of-care therapies, and with its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of different therapeutic and technology applications. The Company’s platform includes devices that utilize a proprietary drug delivery technology and a clinical-stage investigational immunotherapy. The Company’s two Food and Drug Administration (FDA)-cleared devices use its proprietary Pressure-Enabled Drug Delivery (PEDD) approach to deliver a range of therapeutics: the TriNav Infusion System for hepatic arterial infusion of liver tumors and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. PEDD technology is a novel delivery approach designed to address the anatomic limitations of arterial infusion for the pancreas.

Webull offers TriSalus Life Sciences Inc stock information, including NASDAQ: TLSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLSI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLSI stock methods without spending real money on the virtual paper trading platform.